StockData
OraSure Technologies Inc logo

OraSure Technologies Inc (OSUR) stock

OSURNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 11/3038% below fair value
$3.62+0.00 (0.00%)

Close on Nov 13, 2026Market cap $249.67MP/E –Yield –

OraSure Technologies Inc saw revenue fall 7.5% to $116.23M over the twelve months to Sep 30, 2026. Free cash flow was -$49.62M. At the latest close the market valued the company at $249.67M.

Revenue
$116.23M
-7.5% vs. a year earlier
Operating income
-$50.89M
TTM Q3 2026
Free cash flow
-$49.62M
TTM Q3 2026
EPS, diluted
-$0.69
TTM Q3 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$249.67M
P/E ratio
–
Price to sales
2.15
Price to book
0.81
Dividend yield
–
Free cash flow yield
-19.87%

Fundamentals

Revenue
$116.23M
Net income
-$48.51M
EPS, diluted
-$0.69
Free cash flow
-$49.62M
Book value per share
$4.45
Diluted shares
69M

Trading

Next earnings
Feb 24, 2027 (estimated, after the close)
Previous close
$3.62
Open
$3.61
Day's range
$3.54 – $3.68
Volume
409,006
Average volume (20 days)
687,325
Index membership
Russell 2000, Russell 3000
Beta (5 years)
0.93
52-week range
$2.08 – $4.58
RSI (14 days)
47.6
Volatility (1 year)
51.1%
Relative volume
0.78×
WACC
9.7%

On 1 of our idea list: More cash than they're worth

Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2011, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodOSURS&P 500DifferenceOSUR per yearS&P 500 per year
1 month-5.0%-3.0%−1.9 pts
3 months-10.0%-2.8%−7.2 pts
Year to date+49.6%+11.5%+38.1 pts
1 year+58.8%+13.5%+45.3 pts
3 years-44.6%+77.7%−122.3 pts-17.9%+21.1%
5 years-63.6%+72.6%−136.2 pts-18.3%+11.5%
10 years-56.4%+308.2%−364.6 pts-8.0%+15.1%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$116.23M-7.5% YoY

Gross profit

$50.06M-1.5% YoY

Operating income

-$50.89M

Net income

-$48.51M

EPS, diluted

-$0.69

Free cash flow

-$49.62M
Reported periodTrailing twelve months

Press releases

Releases OraSure Technologies filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About OraSure Technologies

Surgical & Medical Instruments & Apparatus

OTI, also known as OraSure Technologies, develops, manufactures, and distributes rapid diagnostic testing products and sample management solutions. Its diagnostic line features rapid point-of-care and over-the-counter self-tests for infectious conditions including HIV, Hepatitis C, COVID-19, and sickle cell disease under brand names like OraQuick and InteliSwab. The company also provides sample collection devices and stabilization solutions for genetic and microbiome research. It serves healthcare providers, clinical and academic laboratories, public health agencies, pharmaceutical firms, and retail consumers directly and through commercial partners.

Company profile, executives and history

OraSure Technologies stock: common questions

What is OraSure Technologies's stock price?

OSUR closed at $3.62 on Nov 13, 2026, up 0.00% on the day. Over the past 52 weeks it traded between $2.08 and $4.58.

What is OraSure Technologies's market cap?

OraSure Technologies was worth $249.67M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.

What is OSUR's P/E ratio?

OraSure Technologies lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.69), so it has no meaningful P/E ratio.

How much revenue does OraSure Technologies make?

OraSure Technologies reported revenue of $116.23M for the twelve months to Sep 30, 2026, down 7.5% from a year earlier.

Does OraSure Technologies pay a dividend?

No. OraSure Technologies has not paid a cash dividend over the last twelve months.

When does OraSure Technologies report earnings next?

OraSure Technologies is expected to report Q4 FY2026 results on Feb 24, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.

How has OSUR stock performed over the past year?

Including dividends, OSUR returned +58.8% over the past year, against +13.5% for the S&P 500.

How many OSUR shares are sold short?

3M shares were sold short at the latest FINRA report, 4.59% of the float, or 3.6 days of average trading volume.

Who are OraSure Technologies's competitors?

Companies most similar to OraSure Technologies by business, industry and size include ANIK, TELA, RCEL, INFU, IRMD.

See a number that looks wrong?